Other countries outside the US are also expressing and formulating their clinical trial business in India. Of late there have been a multitude of these reportings, it doesn’t appear India will be lacking in the R and D trial business any time soon. BD
The operation will be run by the newly formed Oncology Services India (OSI) and gives the company access to a large number of therapy-naive patients.
OSE hopes the move will establish it as a new international “Oncology Specialist” within the global CRO industry.